JAVITT JONATHAN C (Chief Executive Officer) purchased 136.7% of their position (200K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $64.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/23/2023ACC: 0001104659-23-094406
DirectorOfficer10% Owner· Chief Executive Officer
Since May 2021
+200K
Net shares
Net buyer
$64.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
$0.32
Trade value
$64.40K
% of position
136.7%
8/22/2023
146.33K→346.33K
Total
Net shares
+200K
Net value
$64.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/22/2023 | P · Purchase | +200K | $0.32 | $64.40K | 136.7% | 146.33K | 346.33K |
| Total | +200K | $64.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned1.42M
Common Stock
IndirectShares owned300K
Common Stock
IndirectShares owned12.60M
Total
14.32M indirect14.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.42M | Indirect |
| Common Stock | 300K | Indirect |
| Common Stock | 12.60M | Indirect |
| Total | 14.32M | 14.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported